drugset / Trial / NCT03822754
A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this phrase III clinical trial is to evaluate the immunogenicity and safety of Sabin Inactivated Poliovirus Vaccine (Vero cell) in a '1+2' sequential schedule with bivalent oral poliovirus vaccine in 2-month-old infants
Timeline
- Start
- 2018-06-06
- Primary completion
- 2018-09-26
- Completion
- 2018-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sabin Inactivated Poliovirus Vaccine (Vero Cell) | Vaccine | 0.5 ml | Intramuscular |
| Comparator | wild strain inactivated poliovirus vaccine | Vaccine | 0.5 ml | Intramuscular |
| Background | bOPV | Vaccine | 0.1 ml | Oral |